Reactance inversion in moderate to severe persistent asthma: low birth weight, prematurity effect, and bronchodilator

Ramiro González Vera1, Alberto Vidal Grell2, José A Castro-Rodríguez3

  • 1Clínica Las Condes, Santiago, Chile.

Insights

Reactance inversion (RI) is common in children with severe asthma, especially those born prematurely. Persistent RI indicates poorer lung function and may signal small airway dysfunction.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Asthma Research

Background:

  • Reactance inversion (RI) is linked to impaired peripheral airway function in persistent asthma.
  • Limited data exists on clinical and lung function differences between asthmatic children with and without RI.

Purpose of the Study:

  • To identify clinical and lung function differences in moderate-to-severe asthmatic children with and without RI.

Main Methods:

  • Conducted between 2021-2022 with school-aged asthmatic children.
  • Utilized impulse oscillometry (IOS) and spirometry per ATS/ERS standards.
  • Divided 62 patients into three groups: no RI, transient RI, and persistent RI.

Main Results:

  • Children with RI (groups 2 and 3) had lower birth weights and gestational ages than those without (group 1).
  • Groups 2 and 3 showed significantly lower FEV1 and FEF25-75.
  • Persistent RI (group 3) correlated with higher R5, AX, R5-20, R5-R20/R5 values and lower bronchodilator responses.

Conclusions:

  • RI is prevalent in moderate-to-severe persistent asthma, particularly in those with prematurity or low birth weight history.
  • While RI can resolve post-bronchodilator, persistent RI is associated with worse pulmonary function.
  • RI may serve as a marker for small airway dysfunction in pediatric asthma.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
298